Dr Lalchandani Labs Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Mohit Lalchandani

Chief Executive Officer (CEO)

₹1.4m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	6yrs
Participación del CEO	4.9%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	6.1yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mohit Lalchandani en comparación con los beneficios de Dr Lalchandani Labs?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	₹9m
Jun 30 2024	n/a	n/a	₹7m
Mar 31 2024	₹1m	n/a	₹6m
Dec 31 2023	n/a	n/a	-₹304k
Sep 30 2023	n/a	n/a	-₹7m
Jun 30 2023	n/a	n/a	-₹11m
Mar 31 2023	₹1m	n/a	-₹16m
Dec 31 2022	n/a	n/a	-₹13m
Sep 30 2022	n/a	n/a	-₹11m
Jun 30 2022	n/a	n/a	-₹864k
Mar 31 2022	₹1m	₹1m	₹9m
Dec 31 2021	n/a	n/a	₹14m
Sep 30 2021	n/a	n/a	₹19m
Jun 30 2021	n/a	n/a	₹14m
Mar 31 2021	₹1m	₹1m	₹10m
Dec 31 2020	n/a	n/a	₹8m
Sep 30 2020	n/a	n/a	₹3m
Jun 30 2020	n/a	n/a	₹4m
Mar 31 2020	₹1m	₹1m	₹5m
Dec 31 2019	n/a	n/a	₹5m
Sep 30 2019	n/a	n/a	₹7m
Jun 30 2019	n/a	n/a	₹6m
Mar 31 2019	₹1m	₹1m	₹5m
Dec 31 2018	n/a	n/a	₹1m
Sep 30 2018	n/a	n/a	-₹3m
Jun 30 2018	n/a	n/a	-₹226k
Mar 31 2018	₹900k	₹900k	₹3m

Compensación vs. Mercado: La compensación total de Mohit($USD17.05K) está por debajo de la media de empresas de tamaño similar en el mercado Indian ($USD42.63K).

Compensación vs. Ingresos: La compensación de Mohit ha sido consistente con los resultados de la empresa en el último año.

CEO

Mohit Lalchandani (38 yo)

6yrs

Permanencia

₹1,440,000

Compensación

Mr. Mohit Lalchandani serves as Whole-Time Director of Dr Lalchandani Labs Ltd. and has been its Chief Executive Officer since November 2, 2018. Mr. Chandani holds Bachelor of Technology in the field of El...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Arjan Lalchandani	Chairman & MD	no data	₹1.44m	51.85% ₹ 40.4m
Mohit Lalchandani	CEO & Whole Time Director	6.2yrs	₹1.44m	4.87% ₹ 3.8m
Anchal Gupta	CFO & Executive Director	7.3yrs	₹600.00k	0.83% ₹ 650.7k
Prakash Jhuraney	Independent Director	6yrs	sin datos	sin datos
Rajiv Handa	Independent Director	no data	sin datos	sin datos
Swati Chandra	Non-Executive Director	2.7yrs	sin datos	sin datos

6.1yrs

Permanencia media

53.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 541299 se considera experimentada (6.1 años de antigüedad promedio).

Dr Lalchandani Labs Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Chairman & MD recently bought ₹317k worth of stock

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

Recent updates

Chairman & MD recently bought ₹317k worth of stock

First half 2025 earnings released: EPS: ₹0.35 (vs ₹0.20 loss in 1H 2024)

Investor sentiment improves as stock rises 20%

Dr Lalchandani Labs Limited to Report Q2, 2025 Results on Oct 14, 2024

Dr Lalchandani Labs Limited to Report First Half, 2025 Results on Oct 14, 2024

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2024

Full year 2024 earnings released: EPS: ₹1.43 (vs ₹3.61 loss in FY 2023)

New minor risk - Financial data availability

Dr Lalchandani Labs Limited to Report Second Half, 2024 Results on May 30, 2024

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Announces Resignation of Monika Joshi as Company Secretary and Compliance Officer

First half 2024 earnings released: ₹0.20 loss per share (vs ₹2.24 loss in 1H 2023)

New major risk - Financial position

Less than half of directors are independent

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2023

Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023

Less than half of directors are independent

Less than half of directors are independent

New major risk - Revenue and earnings growth

Full year 2023 earnings released: ₹3.61 loss per share (vs ₹2.15 profit in FY 2022)

Less than half of directors are independent

Dr Lalchandani Labs Limited to Report Fiscal Year 2023 Results on May 30, 2023

Less than half of directors are independent

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Management Changes

Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer

First half 2023 earnings released

Less than half of directors are independent

Dr Lalchandani Labs Limited to Report First Half, 2023 Results on Nov 14, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹2.15 (vs ₹2.33 in FY 2021)

Dr Lalchandani Labs Limited, Annual General Meeting, Sep 30, 2022

Less than half of directors are independent

Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer

Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh

Investor sentiment deteriorated over the past week

Dr Lalchandani Labs Limited to Report Fiscal Year 2022 Results on May 30, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2021 earnings released: EPS ₹2.33 (vs ₹1.09 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: ₹13.00

Dr Lalchandani Labs Limited to Report First Half, 2021 Results on Nov 13, 2020

Market pulls back on stock over the past week

New 90-day high: ₹12.10

Full year earnings released - EPS ₹1.09

Dr Lalchandani Labs Limited to Report Fiscal Year 2020 Results on Jun 30, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad